Contribution: Industrial Research Assistance Program – Contributions to Firms
Ekosi Health Centre Corp.
$50,000.00
Implementation of revised Strategic Plan for Ekosi Harm-and-Pharma Reduction Initiative
EF 2021-22 · 2021-06-28
Résumé
This project is focused on continuing to expand the company’s suite of offerings to position it as a market leader in the delivery of services to enhance health and reduce dependence on pharmaceutical interventions. Specifically, a Strategic Plan for the company’s innovative Harm and Pharma Reduction Program is to be implemented as a result of this project.
Ministère
Programme
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (lien de confiance élevée)
Bénéficiaire
Emplacement
Gimli|Gimli, Manitoba, Canada
Type de bénéficiaire
For-profit organization
Numéro d'entreprise
714721313
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Tel que publié
Agreement End Date
2022-02-18
Agreement Number
974069
Agreement Start Date
2021-06-28
Agreement Title
Implementation of revised Strategic Plan for Ekosi Harm-and-Pharma Reduction Initiative
Agreement Title (French)
Mise en œuvre du plan stratégique révisé pour l'initiative Ekosi de réduction des risques et des médicaments (Ekosi Harm-and-Pharma Reduction Initiative)
Agreement Type
Contribution
Agreement Value
$50,000.00
Amendment Number
0
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
This project is focused on continuing to expand the company’s suite of offerings to position it as a market leader in the delivery of services to enhance health and reduce dependence on pharmaceutical interventions. Specifically, a Strategic Plan for the company’s innovative Harm and Pharma Reduction Program is to be implemented as a result of this project.
Description (French)
Ce projet vise à poursuivre l'expansion de la gamme d'offres de l'entreprise afin de la positionner en tant que chef de file du marché dans la prestation de services visant à améliorer la santé et à réduire la dépendance aux interventions pharmaceutiques. Plus précisément, un plan stratégique pour le programme innovant de réduction des risques et des médicaments (Harm and Pharma Reduction Program) de l'entreprise doit être mis en œuvre dans le cadre de ce projet.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Selkirk--Interlake--Eastman
Federal Riding (French)
Selkirk--Interlake--Eastman
Federal Riding Number
46010
NAICS Code
325410
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
714721313
Recipient City
Gimli|Gimli
Recipient Country
CA
Recipient Legal Name
Ekosi Health Centre Corp.
Recipient Operating Name
Ekosi
Recipient Postal Code
R0C 1B0
Recipient Province or Territory
MB
Recipient Type
F
Reference Number
172-2021-2022-Q2-974069
